APA Alıntı

Demuynck, B., Filipo, J., Li, G., Dambkowski, C. L., & Legeai-Mallet, L. (2020). SUN-101 Support for a New Therapeutic Approach of Using a Low-Dose FGFR Tyrosine Kinase Inhibitor (Infigratinib) for Achondroplasia. J Endocr Soc.

Chicago Stili Alıntı

Demuynck, Benoit, Justine Filipo, Gary Li, Carl L. Dambkowski, ve Laurence Legeai-Mallet. "SUN-101 Support for a New Therapeutic Approach of Using a Low-Dose FGFR Tyrosine Kinase Inhibitor (Infigratinib) for Achondroplasia." J Endocr Soc 2020.

MLA Alıntı

Demuynck, Benoit, et al. "SUN-101 Support for a New Therapeutic Approach of Using a Low-Dose FGFR Tyrosine Kinase Inhibitor (Infigratinib) for Achondroplasia." J Endocr Soc 2020.